Literature DB >> 7126439

Assessment of optimum dose of inhaled terbutaline in patients with chronic asthma: the use of simple, cumulative dose-response curves.

J G Prior, G M Cochrane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7126439

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN： 0007-0971


× No keyword cloud information.
  9 in total

1.  A cumulative dose comparison between salbutamol and fenoterol metered dose aerosols in asthmatic patients.

Authors:  D Bellamy; A Penketh
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

2.  Home nebulisers for airflow limitation.

Authors:  G M Cochrane; J G Prior; P J Rees
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-01

3.  Slow release theophyllines and chronic bronchitis.

Authors:  G M Cochrane
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

4.  Screening older patients for obstructive airways disease in a semi-rural practice.

Authors:  J A Dickinson; M Meaker; M Searle; G Ratcliffe
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

5.  Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; R A Brown; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

6.  Underdiagnosed asthma in South Australia.

Authors:  R J Adams; D H Wilson; S Appleton; A Taylor; E Dal Grande; C R Chittleborough; R E Ruffin
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

7.  Regular nebulised terbutaline in chronic obstructive airways disease: dose-response studies fail to detect tolerance.

Authors:  C Teale; S B Pearson
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

8.  Dose response to inhaled salbutamol in chronic obstructive airways disease.

Authors:  C Teale; J F Morrison; R L Page; S B Pearson
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

9.  Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.

Authors:  R Jaeschke; G H Guyatt; A Willan; D Cook; S Harper; J Morris; H Ramsdale; R Haddon; M Newhouse
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.